Rob Lutz, Founder & Editorial Director 
In this episode, naturopathic physician Chris Meletis joins Rob to discuss their personal journeys with cardiometabolic health as they both turn 60 this year. They dive deep into the importance of advanced lipid testing, including markers like lipoprotein(a), apolipoprotein B, and particle size. Chris shares his expertise on optimizing nitricRead
Metabolic disorders like diabetes and metabolic syndrome have reached epidemic proportions, affecting over a third of Americans. Yet these conditions are often viewed as chronic, progressive diseases that can only be managed with medications. However, renowned integrative medicine expert Dr. Jacob Teitelbaum is here to challenge that narrative. In thisRead
Discover how berberine supports metabolic health by improving blood sugar, cholesterol, and inflammation. Backed by clinical research and safe for long-term use.
Explore how gamma cyclodextrin improves the effectiveness of fat-soluble nutrients like berberine, CoQ10, and red ginseng—making them more bioavailable and clinically powerful.
Discover how targeted nutrients like benfotiamine, methylcobalamin, and alpha-lipoic acid support diabetic neuropathy recovery by addressing underlying metabolic and inflammatory pathways.
Hintonia latiflora improves blood sugar levels and reduces the need for medication in early diabetes—see how this traditional herb is supported by clinical science.
Berberine’s absorption is naturally limited. Discover how a gamma-cyclodextrin delivery system boosts its bioavailability and supports more effective dosing strategies in clinical practice.
In this episode of the OneMedicine Podcast, featuring Matt Lim, BAppSc, BHSc, we dive into using nutrigenomics to improve health outcomes with a focus on addressing oxidative stress.. We review nutrigenomics at a high level and discussed activating the NRF2 pathway using compounds like sulforaphane from broccoli sprouts. We discussedRead
NRF2 is a master regulator of antioxidant and anti-inflammatory defenses, making it a vital target in managing chronic diseases like cancer, neurodegeneration, diabetes, and heart disease. This medical review explores NRF2’s clinical significance, disease relevance, and therapeutic modulation using pharmaceuticals and natural compounds.
Apolipoprotein B (ApoB) is a crucial structural protein found in atherogenic lipoproteins, including low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and lipoprotein(a) [Lp(a)]. Unlike other lipid markers such as LDL-C, which measure cholesterol content, ApoB provides a direct count of the number of atherogenic lipoprotein particles, makingRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
